Table 4.
Cell Cycle Phase | CT | 500 µg/mL | 1000 µg/mL | |
---|---|---|---|---|
G0/G1 | 51.32 ± 0.03 | 51.56 ± 2.82 | 56.63 ± 2.31 * | |
DP-MJ | S | 7.70 ±0.46 | 11.97 ± 1.11 * | 8.70 ± 0.66 |
G2/M | 40.97 ± 2.73 | 36.45 ± 0.19 * | 32.27 ± 0.38 * | |
G0/G1 | 41.82 ± 1.63 | 41.62 ± 2.27 | 44.05 ± 2.45 * | |
DP-SC | S | 9.91 ± 1.89 | 12.34 ± 1.26 * | 11.63 ± 1.74 * |
G2/M | 48.25 ±2.47 | 45.72 ± 3.54 * | 43.83± 2.45 * | |
G0/G1 | 40.36 ± 2.45 | 42.36± 1.63 * | 46.31± 2.27 * | |
DP-SM | S | 11.72 ± 1.74 | 11.00 ± 1.69 | 15.84 ± 1.98 * |
G2/M | 47.91 ± 0.01 | 46.62 ± 0.53 | 44.91 ± 0.74 * |
Results are expressed as a percentage of total cells. Significant differences between untreated cells (CT) and cells treated with DP-MJ. DP-SC and DP-MA (500–1000 µg/mL) were compared (* p < 0.05; ** p < 0.01).